Revelation Biosciences, Inc. (REVBW) Ownership

$0.01

south_east
-$0 (9.52%)
Day's range
$0.01
Day's range
$0.01

Revelation Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LINDEN ADVISORS LP 11/14/2024 338,110 $5,071   0.00% 12.62%
YAKIRA CAPITAL MANAGEMENT, INC. 11/13/2024 246,884 $3,703   0.00% 9.21%
WALLEYE CAPITAL LLC 11/14/2024 187,001 $2,805   0.00% 6.98%
PINE VALLEY INVESTMENTS LTD LIABILITY CO 11/25/2024 142,148 $2,133   0.00% 5.30%
WALLEYE TRADING LLC 11/14/2024 104,990 $1,575   0.00% 3.92%
COWEN AND COMPANY, LLC 11/12/2024 99,900 $1,498   -0.10% 3.73%
JANE STREET GROUP, LLC 11/15/2024 50,000 $750   0.00% 1.87%
CITADEL ADVISORS LLC 11/14/2024 29,400 $423   -35.88% 1.10%
WOLVERINE ASSET MANAGEMENT LLC 11/04/2024 22,202 $333   -69.25% 0.83%
TWO SIGMA SECURITIES, LLC 11/14/2024 15,814 $237   100.00% 0.59%
UBS GROUP AG 11/14/2024 2,668 $40   -43.41% 0.10%
POM INVESTMENT STRATEGIES, LLC 10/18/2024 1,005 $15   0.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 0 $0   -100.00% 0.00%
PRIVIUM FUND MANAGEMENT B.V. 11/01/2024 0 $0   -100.00% 0.00%

Revelation Biosciences, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of REVBW shares?

During the previous two years, 17 institutional investors and hedge funds held shares of Revelation Biosciences, Inc.. The most heavily invested institutionals were:

LINDEN ADVISORS LP: 338,110

Yakira Capital Management, Inc.: 246,884

Walleye Capital LLC: 187,001

Pine Valley Investments Ltd Liability Co: 142,148

Walleye Trading LLC: 104,990

COWEN AND COMPANY, LLC: 99,900

What percentage of Revelation Biosciences, Inc. stock is owned by institutional investors?

46.27% of Revelation Biosciences, Inc. stock is owned by institutional investors.

How much institutional buying is happening at REVBW ?

Institutional investors have bought a total of 1.69 M shares in the last 24 months. This purchase volume represents approximately $16,916 in transactions.